AzTrials
AzTrials

Research institution

Peking University First Hospital Clinical Trials

Studies where Peking University First Hospital is the lead sponsor: what is enrolling now, by phase, condition and country.

387 registered studies

In numbers

Open to volunteers
152
Active
166
With results posted
2
All registered
387

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 152
  • Old Age; Debility, Digestive Cancer

    Perioperative Multicomponent Rehabilitation and Outcomes in Elderly Patients With Frailty

    • Recruiting
    • Age: 65 to 89 years
    • Pill or oral medicine
    • Lifestyle or therapy programme

    The study is designed to investigate the effect of a perioperative multicomponent rehabilitation pathway on early and long-term outcomes in elderly patients with frailty recovering from surgery for digestive cancer.

    Conditions
    Old Age; Debility, Digestive Cancer, Surgery, Nutrition Therapy
    Trial name
    NCT04715581
    Testing
    Preoperative nutritional optimization, Perioperative exercise training, Postoperative exercise training
    Where
    China
    Volunteers
    540 people
    Sponsor
    Peking University First Hospital
    Can I take part? NCT04715581
  • Elderly, Cancer Surgery

    Perioperative Dexmedetomidine and Long-term Survival After Cancer Surgery

    • Recruiting
    • Age: 60 years and older
    • Injection or infusion

    Along with aging population, cancer incidence and mortality are increasing. However, despite advances in oncology and surgery, long-term survival of cancer patients is far from optimal.

    Conditions
    Elderly, Cancer Surgery, Dexmedetomidine, Long-Term Survivors
    Trial name
    NCT06030804
    Testing
    Dexmedetomidine
    Where
    40 sites in China
    Volunteers
    4,532 people
    Sponsor
    Peking University First Hospital
    Can I take part? NCT06030804
  • Laparoscopic Surgery, Visceral Pain, Postoperative

    Anrikefon-based Patient-controlled Intravenous Analgesia Following Laparoscopic Surgery

    • Recruiting
    • Age: 18 to 75 years
    • Phase 4
    • Injection or infusion

    Visceral pain following laparoscopic surgery is frequently underestimated, yet it is associated with a range of adverse outcomes.

    Conditions
    Laparoscopic Surgery, Visceral Pain, Postoperative, Anrikefon, Patient-controlled Intravenous Analgesia
    Trial name
    NCT07525986
    Testing
    High-dose anrikefon, Medium-dose anrikefon, Low-dose anrikefon
    Where
    4 sites in China
    Volunteers
    140 people
    Sponsor
    Peking University First Hospital
    Can I take part? NCT07525986
  • Sleep Apnea, Obstructive, Sleep Staging

    Development and Clinical Validation of Artificial Intelligence Algorithms for Sleep Staging and Obstructive Sleep Apnea Screening Based on a Large-Scale Model Trained on Multimodal Physiological Signals From Diverse Populations

    • Recruiting
    • Age: 18 to 65 years
    • Observational study

    In recent years, wearable and contactless devices, including smart rings, smart bands/watches, and smart mattresses, have developed rapidly and can continuously collect multidimensional data such as heart rate, oxygen saturation…

    Conditions
    Sleep Apnea, Obstructive, Sleep Staging, Screening
    Trial name
    NCT07908160
    Where
    China
    Volunteers
    1,000 people, healthy volunteers welcome
    Sponsor
    Peking University First Hospital
    Can I take part? NCT07908160
  • Urothelial Carcinoma of the Renal Pelvis and Ureter, Neoadjuvant Therapy

    Neoadjuvant Disitamab Vedotin, Toripalimab, and Radiotherapy for High-risk UTUC ( LUXUS07.1 )

    • Not yet recruiting
    • Age: 18 years and older
    • Phase 2
    • Injection or infusion
    • Surgery or procedure

    This is an open-label, single-arm, single-cohort, prospective clinical study evaluating neoadjuvant antibody-drug conjugate therapy combined with immunotherapy and sequential radiotherapy followed by radical surgery in patients…

    Trial name
    LUXUS0701 (NCT07720921)
    Testing
    Neoadjuvant radiotherapy, ADC + PD1 monoclonal antibody
    Where
    China
    Volunteers
    20 people
    Sponsor
    Peking University First Hospital
    Can I take part? LUXUS0701
  • Limb Girdle Muscular Dystrophy Type 2D/R3

    BBM-L101 Gene Therapy in Participants With LGMD2D/R3

    • Not yet recruiting
    • Age: 4 to 13 years
    • Phase 1
    • Injection or infusion

    This phase 1 study will evaluate a single intravenous infusion of BBM-L101, an investigational AAV-based gene therapy designed to deliver a functional SGCA gene, in ambulatory children aged 4 to <13 years with genetically…

    Trial name
    NCT07874516
    Testing
    BBM-L101 Injection
    Where
    China
    Volunteers
    8 people
    Sponsor
    Peking University First Hospital
    Can I take part? NCT07874516
  • Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma

    68Ga- and 18F-CAIX PET Imaging Study

    • Not yet recruiting
    • Age: 18 years and older
    • Early Phase 1
    • Injection or infusion

    This exploratory clinical imaging study will evaluate the safety, tolerability, biodistribution, lesion detection, and tumor uptake characteristics of 68Ga- and 18F-labeled carbonic anhydrase IX (CAIX)-targeted positron emission…

    Conditions
    Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Renal Tumor
    Trial name
    CAIX-PET (NCT07875946)
    Testing
    68Ga-CAIX PET/CT, 18F-CAIX
    Where
    China
    Volunteers
    100 people, healthy volunteers welcome
    Sponsor
    Peking University First Hospital
    Can I take part? CAIX-PET
  • Renal Cell Carcinoma (RCC), Renal Pelvic Urothelial Carcinoma

    18F-N230A PET/CT Imaging of Nectin-4 Expression in Renal Tumors

    • Recruiting
    • Age: 18 years and older
    • Injection or infusion

    Renal cell carcinoma and renal pelvic urothelial carcinoma are common malignant tumors of the urinary system. Accurate preoperative differentiation between these tumor types is important for treatment planning, while conventional…

    Trial name
    NCT07875959
    Testing
    18F-N230A
    Where
    China
    Volunteers
    80 people
    Sponsor
    Peking University First Hospital
    Can I take part? NCT07875959
  • Older Patients, Surgery

    Dexmedetomidine-esketamine and tDCS for Prevention of Neurocognitive Complications After Surgery

    • Not yet recruiting
    • Age: 65 years and older
    • Phase 4
    • Injection or infusion
    • Medical device

    Neurocognitive complications, mainly delirium and neurocognitive disorders, are common cerebral complications in older patients after surgery and associated with worse outcomes.

    Conditions
    Older Patients, Surgery, Dexmedetomidine, Esketamine
    Trial name
    NCT07576517
    Testing
    Dex-Esk, Active tDCS
    Where
    6 sites in China
    Volunteers
    1,996 people, healthy volunteers welcome
    Sponsor
    Peking University First Hospital
    Can I take part? NCT07576517
  • Older Patients, Surgery

    Long-term Follow-up of Dexmedetomidine-esketamine and tDCS for Neurocognitive Complications After Surgery

    • Not yet recruiting
    • Age: 65 years and older
    • Phase 4
    • Injection or infusion
    • Medical device

    Neurocognitive complications, mainly delirium and neurocognitive disorders, are common cerebral complications in older patients after surgery and associated with worse long-term outcomes.

    Conditions
    Older Patients, Surgery, Dexmedetomidine, Esketamine
    Trial name
    NCT07576543
    Testing
    Dex-Esk, Active tDCS
    Where
    6 sites in China
    Volunteers
    1,996 people, healthy volunteers welcome
    Sponsor
    Peking University First Hospital
    Can I take part? NCT07576543

Completed, with results posted

All –
  • Peritoneal Dialysis Associated Peritonitis

    Vancomycin Plus Moxifloxacin Versus Vancomycin Plus Ceftazidime for the Treatment of Peritoneal Dialysis (PD)-Related Peritonitis

    • Completed
    • Age: 18 years and older
    • Pill or oral medicine
    • Results posted

    Intra-peritoneal administration of antibiotics covering both gram-positive and gram-negative organisms was recommended as first-line regimen for the management of peritoneal dialysis related peritonitis.

    Trial name
    PD (NCT02787057)
    Testing
    vancomycin, moxifloxacin, ceftazidime
    Volunteers
    80 people
    Sponsor
    Peking University First Hospital
    Can I take part? PD
  • Delirium, C.Surgical Procedure; Cardiac

    Dexmedetomidine and Delirium in Patients After Cardiac Surgery

    • Completed
    • Age: 60 to 90 years
    • Phase 4
    • Injection or infusion
    • Results posted

    Postoperative delirium (POD) is a frequently occurring complication after cardiac surgery. Its occurrence is associated with worse outcomes of patients, including increased morbidity, prolonged hospital stay, increased medical…

    Conditions
    Delirium, C.Surgical Procedure; Cardiac, Postoperative Complications
    Trial name
    NCT02267538
    Testing
    dexmedetomidine hydrochloride for injection, 0.9% sodium chloride for injection
    Where
    China
    Volunteers
    285 people
    Sponsor
    Peking University First Hospital

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in